Browse studies

Find your next paid study

7 recruiting studies matching your filters

Feasibility Evaluation of a Strap-Based Wearable Optical Device (Hemorai Vysio) for Monitoring Hemodynamic Trends and Early Indicators of Blood Loss in Perioperative and Postoperative Patients

The goal of this clinical trial is to learn whether the Hemorai Vysio wearable device can be used safely and feasibly to track relative changes over time in ti…

Blood Loss, SurgicalPostoperative Hemorrhage

Estimated

~$10 – $8,750

Hemorai IncNCT07826637

Evaluation of the Clinical Performance of the Quantra System With the QPlus Cartridge in Pediatric Patients Undergoing Cardiovascular Procedures

This study will evaluate the performance of the Quantra System with the QPlus Cartridge in pediatric patients undergoing cardiovascular procedures.

Blood Loss, Surgical

Estimated

~$10 – $1,050

HemoSonics LLCNCT07597278

Phase 3

A Phase 3 Prospective Randomised Clinical Trial of VMX-C001 vs Usual Pharmacological Care in Patients Receiving a FXa Direct Oral Anticoagulant (FXa DOAC) Who Require Urgent Surgery or Other Invasive Procedure That is Associated With a High Risk of Bleeding, With or Without Planned Administration of Heparin (EQUILIBRIX-S)

The goal of this clinical trial is to learn if VMX-C001 works to to allow blood clotting control in participants who take FXa Direct Oral Anticoagulants (DOACs…

Blood Loss, SurgicalCoagulation Disorder

Estimated

~$10 – $7,500

VarmX B.V.NCT07288489

Phase 2

Phase II, Randomized, Double Blinded, Placebo Controlled Superiority Trial of Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery in Pregnant Patients at High Risk for Uterine Atony

This research study is being done to learn what effect a single dose of calcium gluconate will have on blood loss at the time of cesarean delivery in pregnancy…

Blood Loss, SurgicalBlood Loss, PostoperativeUterine Atony

Estimated

~$10 – $6,250

University of MichiganNCT07217899

Phase 4

Role of Intravenous Tranexamic Acid Use in Patients Undergoing Breast Free Flap Reconstruction: Randomized Controlled Trial

Tranexamic acid (TXA) is a synthetic, competitive lysine receptor inhibitor on plasminogen. It ultimately stabilizes the fibrin matrix, therefore used as a hem…

Breast CancerBlood Loss, Surgical

Estimated

~$10 – $6,250

University of VirginiaNCT06428682

Phase 3

Topical Tranexamic Acid as a Adjunct to Intravenous Tranexamic Acid in Adult Spinal Deformity Surgery

Posterior spinal surgery for adult deformity is associated with high incidence of blood loss and need for blood transfusion and intraoperative blood salvage, w…

Spinal DeformityDegenerative Lumbar Spinal StenosisBlood Loss, Surgical

Estimated

~$10 – $6,250

Hospital for Special Surgery, New YorkNCT03553186

Observational

Delivering Transcutaneous Auricular Neurostimulation to Reduce Blood Loss During Dialysis AV Graft Placement Procedures

The objective of this study is to determine if tAN therapy can reduce the volume of blood lost during dialysis AV graft placement procedures.

Blood Loss, Surgical

Estimated

~$10 – $6,250

University Surgical VascularNCT06647017